Business Description
Renhe Pharmacy Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000NF8
Share Class Description:
SZSE:000650: Class ACompare
Compare
Traded in other countries / regions
000650.China IPO Date
1996-12-10Description
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5713.67 | |||||
| Equity-to-Asset | 0.8 | |||||
| Interest Coverage | 5634.97 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 8.36 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.4 | |||||
| 3-Year EBITDA Growth Rate | -0.1 | |||||
| 3-Year EPS without NRI Growth Rate | -9.4 | |||||
| 3-Year FCF Growth Rate | -24.6 | |||||
| 3-Year Book Growth Rate | 5.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 26.91 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.19 | |||||
| 9-Day RSI | 44.98 | |||||
| 14-Day RSI | 46.9 | |||||
| 6-1 Month Momentum % | 0.85 | |||||
| 12-1 Month Momentum % | -8.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | |||||
| Quick Ratio | 5.7 | |||||
| Cash Ratio | 4.47 | |||||
| Days Inventory | 53.98 | |||||
| Days Sales Outstanding | 57.28 | |||||
| Days Payable | 41.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.41 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 3.41 | |||||
| 5-Year Yield-on-Cost % | 6.17 | |||||
| Shareholder Yield % | 3.52 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.75 | |||||
| Operating Margin % | 20.53 | |||||
| Net Margin % | 10.14 | |||||
| FCF Margin % | 6.86 | |||||
| ROE % | 7.25 | |||||
| ROA % | 5.7 | |||||
| ROIC % | 17.07 | |||||
| ROC (Joel Greenblatt) % | 42.18 | |||||
| ROCE % | 10.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.38 | |||||
| Forward PE Ratio | 9.67 | |||||
| PE Ratio without NRI | 13.38 | |||||
| Shiller PE Ratio | 14.05 | |||||
| Price-to-Owner-Earnings | 46.51 | |||||
| PEG Ratio | 6.69 | |||||
| PS Ratio | 1.87 | |||||
| PB Ratio | 1.35 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| Price-to-Free-Cash-Flow | 26.28 | |||||
| Price-to-Operating-Cash-Flow | 13.7 | |||||
| EV-to-EBIT | 7.76 | |||||
| EV-to-EBITDA | 7.76 | |||||
| EV-to-Revenue | 1.29 | |||||
| EV-to-FCF | 16.05 | |||||
| Price-to-Projected-FCF | 0.84 | |||||
| Price-to-Median-PS-Value | 0.95 | |||||
| Price-to-Graham-Number | 0.98 | |||||
| Price-to-Net-Current-Asset-Value | 2.66 | |||||
| Price-to-Net-Cash | 4.54 | |||||
| Earnings Yield (Greenblatt) % | 12.89 | |||||
| FCF Yield % | 3.63 | |||||
| Forward Rate of Return (Yacktman) % | 6.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Renhe Pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,364.091 | ||
| EPS (TTM) (Â¥) | 0.321 | ||
| Beta | 1.18 | ||
| Volatility % | 32.59 | ||
| 14-Day RSI | 46.9 | ||
| 14-Day ATR (Â¥) | 0.102905 | ||
| 20-Day SMA (Â¥) | 5.969 | ||
| 12-1 Month Momentum % | -8.8 | ||
| 52-Week Range (Â¥) | 5.09 - 7.42 | ||
| Shares Outstanding (Mil) | 1,399.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Renhe Pharmacy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Renhe Pharmacy Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Renhe Pharmacy Co Ltd Frequently Asked Questions
What is Renhe Pharmacy Co Ltd(SZSE:000650)'s stock price today?
The current price of SZSE:000650 is ¥5.90. The 52 week high of SZSE:000650 is ¥7.42 and 52 week low is ¥5.09.
When is next earnings date of Renhe Pharmacy Co Ltd(SZSE:000650)?
The next earnings date of Renhe Pharmacy Co Ltd(SZSE:000650) is .
Does Renhe Pharmacy Co Ltd(SZSE:000650) pay dividends? If so, how much?
The Dividend Yield %  of Renhe Pharmacy Co Ltd(SZSE:000650) is 3.41% (As of Today), Highest Dividend Payout Ratio of Renhe Pharmacy Co Ltd(SZSE:000650) was 0.63. The lowest was 0.08. And the median was 0.28. The  Forward Dividend Yield % of Renhe Pharmacy Co Ltd(SZSE:000650) is 3.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers